1 December 2023 false No description of principal activity Taxfiler 2024.6 14506914business:PrivateLimitedCompanyLtd2023-12-012024-11-30 145069142023-11-30 145069142023-12-012024-11-30 14506914business:AuditExempt-NoAccountantsReport2023-12-012024-11-30 14506914business:FilletedAccounts2023-12-012024-11-30 145069142024-11-30 14506914business:Director12023-12-012024-11-30 14506914business:RegisteredOffice2023-12-012024-11-30 145069142023-11-30 14506914core:AfterOneYear2024-11-30 14506914core:AfterOneYear2023-11-30 14506914core:ShareCapitalcore:PreviouslyStatedAmount2024-11-30 14506914core:ShareCapitalcore:PreviouslyStatedAmount2023-11-30 14506914core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-11-30 14506914core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-11-30 14506914core:PreviouslyStatedAmount2024-11-30 14506914core:PreviouslyStatedAmount2023-11-30 14506914business:SmallEntities2023-12-012024-11-30 14506914countries:EnglandWales2023-12-012024-11-30 14506914core:ComputerEquipment2023-12-012024-11-30 14506914core:Goodwill2023-11-30 14506914core:Goodwill2024-11-30 14506914core:Goodwill2023-12-012024-11-30 14506914core:ComputerEquipment2023-11-30 14506914core:ComputerEquipment2024-11-30 145069142022-11-252023-11-30 iso4217:GBP xbrli:pure
Company Registration No. 14506914 (England and Wales)
Cura Pharma Services Ltd Unaudited accounts for the year ended 30 November 2024
Cura Pharma Services Ltd Unaudited accounts Contents
Page
- 2 -
Cura Pharma Services Ltd Company Information for the year ended 30 November 2024
Director
Moyosoreoluwa Christiana Ogunfowoke
Company Number
14506914 (England and Wales)
Registered Office
19 A, The circle Dilton Marsh Westbury BA13 4BZ
- 3 -
Cura Pharma Services Ltd Statement of financial position as at 30 November 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
9,600 
10,800 
Tangible assets
1,744 
2,325 
11,344 
13,125 
Current assets
Cash at bank and in hand
394 
133 
Net current assets
394 
133 
Total assets less current liabilities
11,738 
13,258 
Creditors: amounts falling due after more than one year
(4,994)
(3,631)
Net assets
6,744 
9,627 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
6,743 
9,626 
Shareholders' funds
6,744 
9,627 
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 January 2025 and were signed on its behalf by
Moyosoreoluwa Christiana Ogunfowoke Director Company Registration No. 14506914
- 4 -
Cura Pharma Services Ltd Notes to the Accounts for the year ended 30 November 2024
1
Statutory information
Cura Pharma Services Ltd is a private company, limited by shares, registered in England and Wales, registration number 14506914. The registered office is 19 A, The circle, Dilton Marsh, Westbury, BA13 4BZ.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% reduce balance basis
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 December 2023
12,000 
At 30 November 2024
12,000 
Amortisation
At 1 December 2023
1,200 
Charge for the year
1,200 
At 30 November 2024
2,400 
Net book value
At 30 November 2024
9,600 
At 30 November 2023
10,800 
- 5 -
Cura Pharma Services Ltd Notes to the Accounts for the year ended 30 November 2024
5
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 December 2023
3,100 
At 30 November 2024
3,100 
Depreciation
At 1 December 2023
775 
Charge for the year
581 
At 30 November 2024
1,356 
Net book value
At 30 November 2024
1,744 
At 30 November 2023
2,325 
6
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Taxes and social security
4,316 
2,651 
Loans from directors
78 
80 
Accruals
600 
900 
4,994 
3,631 
7
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -